Here, using RNA interference and pharmacologic approaches, we provided solid evidence that the overexpression of RNF38 contributes to HCC cell EMT through facilitating TGF-β signaling by the ubiquitination of AHNAK. Here, AHNAK is linked to hepatocellular carcinoma.